Jill Wood

USPTO Trademark & Patent Filings

Trademark applications and grants for Jill Wood. Jill Wood has 1 trademark applications. The latest application filed is for "ZEAL ENERGY"

Company Profile

Jill Wood
jill wood
WOOD; Jill - North Haven CT
WOOD; Jill - Hamden CT
Wood; Jill - Hamden CT
Wood; Jill - Ft. Collins CO
Wood; Jill - North Haven CT
Wood; Jill - Fort Collins CO

Entity Type	INDIVIDUAL
Address	433 Fenton NE Canton, OHIO UNITED STATES 44704

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents

Patent Applications

Patent Application	Date
SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS 20130261113 - 13/908566 HENTEMANN; Martin ; et al.	2013-10-03
INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS 20120149706 - 13/401272 DUMAS; Jacques ; et al.	2012-06-14
INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS 20120046290 - 11/932548 Dumas; Jacques ; et al.	2012-02-23
SULFONE SUBSTITUTED 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES WITH ANGIOGENESIS 20110190281 - 12/812911 Hentemann; Martin ; et al.	2011-08-04
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis 20110083984 - 12/517875 Hentemann; Martin ; et al.	2011-04-14
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis RE46,856 - 15/398,916 Hentemann , et al. May 22, 2	2018-05-22
Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis 8,859,572 - 12/812,911 Hentemann , et al. October 14, 2	2014-10-14
Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis 8,859,572 - 12/812,911 Hentemann , et al. October 14, 2	2014-10-14
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis 8,466,283 - 12/517,875 Hentemann , et al. June 18, 2	2013-06-18
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis 8,466,283 - 12/517,875 Hentemann , et al. June 18, 2	2013-06-18

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"ZEAL ENERGY" 97406317	ZEAL ENERGY 2022-05-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.